Drug Profile
Nerium oleander extract - Ozelle Pharmaceuticals
Alternative Names: Anvirzel; NOE - Ozelle Pharmaceuticals; Oleandrin - Ozelle PharmaceuticalsLatest Information Update: 20 Jul 2011
Price :
$50
*
At a glance
- Originator Ozelle Pharmaceuticals
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 20 Jul 2011 No Development Reported - Phase-I for Solid tumours in USA (IM)
- 23 Mar 2007 Development is ongoing in the US
- 13 Apr 2000 Phase-I clinical trials in Solid tumours in USA (IM)